Dr. Jeffrey Berger

prevention focused cardiologist; platelet scientist; thrombosis & vascular medicine specialist; proud husband & father of fantastic girls; @NYUCVDPrevent

[Dr. Jeffrey Berger @PlateletDoc]

Finally! A circulating platelet genetic signature (PRESS)🔥that predicts platelet hyperreactivity and increased cardiovascular risk. Collaborative science is awesome!! @TessaJBarrett @NSmilowitzMD @NYUCVDPrevent @NYULHCVRC
https://t.co/LMZLuMjABq

[Dr. Jeffrey Berger @PlateletDoc]

Dr. Sean Heffron of @NYUCVDPrevent, in collaboration with @American_Heart, is highlighting why talking about weight can be challenging - but is essential to empowering patients and protecting long-term #HeartHealth through effective weight management https://t.co/GQ6PwsrAy2

[NYU CVD Prevention @NYUCVDPrevent]

What if talking about your weight with your doctor could be the first step toward better health?

Our Center’s preventive cardiologist, Dr. Sean Heffron, says it’s a crucial conversation: “Every organ system is adversely affected by excess body weight.”⤵️

https://t.co/W44dbdQzbW

[Dr. Jeffrey Berger @PlateletDoc]

Great collaboration between @Perlmutter_CC and @NYUCVDPrevent demonstrating divergent Effects of #GnRH Agonist & GnRH Antagonist Treatment on #Platelet Activity and Transcriptome | JACC: CardioOncology @JACCJournals @nyulangone https://t.co/JM48SzARlm

[NYU Grossman School of Medicine @nyugrossman]

In the prospective POPPY study, @nyulangone researchers linked first-trimester platelet hyperreactivity to nearly fourfold higher odds of ischemic placental disease—and to higher platelet aggregation despite taking aspirin 81 mg daily.

Read more ⤵️ https://t.co/xM0dGCdsh9

[Dr. Jeffrey Berger @PlateletDoc]

@rblument1 @glennfishman Thank you - I have had some outstanding mentors (including you!!!)

[Dr. Jeffrey Berger @PlateletDoc]

@rblument1 @glennfishman Thank you!! I have been fortunate to be mentored by some outstanding mentors (including you!!!)

[NYU CVD Prevention @NYUCVDPrevent]

Proud to be named by @healthcentral as one of its 10 Centers of Excellence in Cardiovascular Care.

The report recognizes our Center's multidisciplinary approach & specialized programs, including Cardio-Rheumatology and Postpartum Cardiovascular Health.

https://t.co/MRJlDQiN8r

[NYU CVD Prevention @NYUCVDPrevent]

Congratulations to Dr. Edward A. Fisher on winning the prestigious 2026 Leducq Foundation award! Dr. Fisher will co-lead a $9M global network studying how #obesity & weight cycling impacts #CVD risk.

➡️https://t.co/QFTyRxixKB

@edwardfisher20 @PlateletDoc @ChiaraGiannare1

[NYU CVD Prevention @NYUCVDPrevent]

Congrats to Dr. Mark Steuerwald our preventive cardiology fellow, on passing the lipid boards (@nationallipid).

Becoming a Diplomate of the American Board of Clinical Lipidology is the highest benchmark of professional competency in Clinical Lipidology.

Well deserved! 👏

[NYU CVD Prevention @NYUCVDPrevent]

📣New in AJPC: AHA #Lipoprotein(a) Discovery Project

Congrats to Dr. Howard Weintraub and colleagues on this publication! This 3 year project was instrumental in developing foundational clinician & patient education resources to advance #LPA awareness.

https://t.co/UInu7jjUum

[Melissa Wong @MelissaWongMD]

Hey, that's @CAPenfield , an outstanding former @OBGYN_CS resident! @mysmfm #SMFM23

[Dr. Jeffrey Berger @PlateletDoc]

Being presented by #MFM specialist Dr Christina Penfield - an outstanding physician scientist - at @MySMFM - exciting ongoing work connecting the link between platelets and adverse pregnancy outcomes #preeclampsia #HDP

[Dr. Jeffrey Berger @PlateletDoc]

Incredible collaboration between #Cardiology and #Obstetrics demonstrating #Platelet hyperreactivity in #pregnancy and risk of ischemic placental disease: The POPPY Study #plateletlab https://t.co/p8Z2heYXQa @ACOGPregnancy @Pregnancy @NYULH_DeptofMed @nyulangone @NYUCVDPrevent

[NYU CVD Prevention @NYUCVDPrevent]

🗞️Now on @JCI_insight! Monocyte #platelet aggregates (MPA) emerges as a biomarker of thromboinflammation. TIPS, a platelet RNA signature, captures thromboinflammation and holds promise for cardiovascular risk stratification and therapeutic targeting.

https://t.co/ruQxoFXtjW

[Dr. Jeffrey Berger @PlateletDoc]

Finally - a #platelet genetic signature (TIPS)🔥of #thromboinflammation and increased cardiovascular risk. Collaborative science is awesome!! https://t.co/Us7nQ1pbrl
@TessaJBarrett
@garshick
@NYUCVDPrevent
@NYULHCVRC @JCI_insight

[NYU CVD Prevention @NYUCVDPrevent]

Why are #PCSK9 inhibitors still underutilized?

Join leading lipid expert Dr. James Underberg to explore how PCSK9 inhibitors can help patients with ASCVD, HeFH, & HoFH #knowFH achieve LDL-C goals that have remained out of reach with standard therapies.

🔗https://t.co/Cr3AAx5Hvt

[NYU CVD Prevention @NYUCVDPrevent]

📢 Don’t miss this CME! Join us on Dec 4 (NYC/online), to hear #CKM health expert Chiadi Ndumele, MD, PhD, MHS, discuss optimal strategies for enhancing cardiovascular-kidney-metabolic health.

Save your seat: https://t.co/Cr3AAx5Hvt

Jointly provided @nyugrossman & @NewYorkACP

[NYU CVD Prevention @NYUCVDPrevent]

📰Now available via @ScienceAdvances!

Our investigators and colleagues report on work that identifies the mechanism of platelet-induced mitochondrial dysfunction in myocardial dysfunction
@plateletdoc

➡️https://t.co/7oFrUrR1IW

[Dr. Jeffrey Berger @PlateletDoc]

Thank you @ScienceAdvances for publishing our collaborative effort demonstrating how #Platelets induce vascular dysfunction in myocardial infarction @JoshuaBeckmanMD @TessaJBarrett @smilowitz @NYUCVDPrevent @NYULHCVRC https://t.co/9T5T7DcyjZ

[NYU CVD Prevention @NYUCVDPrevent]

Personalized #CVD prevention is on the horizon!

Today at #AHA25 (1:59-2:04pm), Dr. Carine Hamo will share details about PROSPER, a circulating plasma protein signature that identifies heightened platelet activity & predicts CVD risk.

Pop Sci Zone
Mod Dig Poster 10
AI.MDP.23